US2019201408A1PendingUtilityA1

6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors

70
Assignee: NATCO PHARMA LTDPriority: Jan 18, 2008Filed: Mar 11, 2019Published: Jul 4, 2019
Est. expiryJan 18, 2028(~1.5 yrs left)· nominal 20-yr term from priority
A61K 31/5377C07D 239/94A61P 43/00A61P 35/00A61K 31/517
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of inhibiting a receptor tyrosine kinase in a subject in need thereof. Methods of inhibiting the growth of a tumor cell in a subject in need thereof. Methods of treating pancreatic cancer in a subject in need of treatment for pancreatic cancer. Methods of treating HER2 positive breast cancer in a subject in need of treatment for HER2 positive breast cancer. Methods of treating drug resistant non-small cell lung cancer in a subject in need of treatment for drug resistant non-small cell lung cancer. Each of these methods can include administering to the subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.

Claims

exact text as granted — not AI-modified
1 .- 52 . (canceled) 
     
     
         53 . A method of treating pancreatic cancer in a subject in need thereof, the method comprising:
 administering to the subject an effective amount of a compound of formula (IA)   
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof 
       
     
     
         54 . The method of claim  3 , wherein the pharmaceutically acceptable salt is a monohydrochloride, a dihydrochloride, or a mixture thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.